FPH pulled the trigger early.
The world depends on them.Humidifier conditions air to body temperature and 100 % humidity and attaches to ventilator (not made by FPH)
70-80% of world sales
Includes neonatal,non invasive ventilation,70 L/m ventilation high flow nasal therapy keeps 70 % of patients off ventilators,change in clinical practice even non Covid
Clinicians seeing the benefits for 4 million Covid patients over time demonstrates benefit so post Covid clinicians see 50 million patients would benefit
Suppliers supplying 5 X normal supplies....... sales ......
https://www.stuff.co.nz/national/the...kel-healthcare